Concepedia

Avantika S. Chitre

AS

Statistics

Publications

8

Citations

1.9K

H-Index

8

Active since

2014

Affiliations

Gene Therapy Laboratory(Current)

Genesys (United States)

University of California, San Francisco

Avantika S. Chitre is an author at Gene Therapy Laboratory specializing in immunology, tumor immunology, and life sciences.

ORCID

Publications per year

2014–2024

8

Publications

8

Peripheral T cell expansion predicts tumour infiltration and clinical response

Thomas D. Wu, Shravan Madireddi, Patrícia E. de Almeida et al. · Nature · 2020 · 795 citations

, , +16

Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer

Namrata S. Patil, Barzin Y. Nabet, Sören Müller et al. · Cancer Cell · 2022 · 403 citations

, , +16

Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses

Karl L. Banta, Xiaozheng Xu, Avantika S. Chitre et al. · Immunity · 2022 · 347 citations · Full text

, , +17

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade

Romain Banchereau, Avantika S. Chitre, Alexis Scherl et al. · Journal for ImmunoTherapy of Cancer · 2021 · 147 citations · Full text

, , +17

CD96 functions as a co‐stimulatory receptor to enhance CD8 <sup>+</sup> T cell activation and effector responses

Eugene Y. Chiang, Patricia E. de Almeida, Denise E. de Almeida Nagata et al. · European Journal of Immunology · 2020 · 98 citations · Full text

, , +17

1–5 of 8